What this study is
Sudden cardiac arrest is a major health problem, and most people don't survive. One big reason is that even if resuscitation is successful, people commonly have recurrent cardiac arrests (rearrest). Right now, it is not possible to accurately predict a rearrest or prevent it. The investigators have developed a machine learning device that uses the heart tracing (ECG) to predict when and why a rearrest occurs. The investigators plan to test if it will accurately and effectively help EMS providers predict rearrest and provide timely treatment to increase survival after cardiac arrest. To determine if this machine learning device will work in the real world, the investigators need to find out if there are barriers to using it, and whether EMS providers will think it is useful and will help them improve the care of patients who have a cardiac arrest. The investigators will first test the device in live simulated cardiac arrest scenarios to see if the providers can use it and if they find the device potentially valuable in taking care of patients. In a second study, the investigators will test how accurate the device is in predicting if a cardiac arrest will happen again in patients who have just been brought back to life after a cardiac arrest. EMS providers will attach the device, but it will only work in the background. EMS will take care of patients as they normally would, without using or knowing what the device says. To see if the device is accurate at predicting another cardiac arrest, the investigators will analyze the results offline, and compare what the device says to what actually happens to the patient. By comparing what the device predicts to what actually happens, the investigators can see how well it predicts another cardiac arrest and estimate how it might improve treatment of patients.
What's being tested
- Machine learning-guided cardiac arrest prediction device
Intervention · DEVICE
A machine learning-guided cardiac arrest prediction device will be used to predict recurrence of cardiac arrest after initially successful resuscitation. It will also predict if the recurrent cardiac arrest is caused by ventricular fibrillation/tachycardia or pulseless electrical activity.
Study details
- Official title
- Improving Cardiac Arrest Outcomes Using Artificial Intelligence Guided Precision Treatments
- Sponsor
- MetroHealth Medical Center
- Conditions
- Sudden Cardiac Arrest
- Enrolling
- 68 people
- Starts
- 2026-08
- Est. completion
- 2029-06
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Adult (18 years of age or older) EMS providers (Simulation trial)
- Adult (18 years of age or older) patients have attempted resuscitation from out-of-hospital SCA of any etiology (Clinical trail)
You can't join if
- Non-English-speaking providers
- Providers who do not care for cardiac arrest patients
- Prisoners
- Pediatric patients under age of 18
- DNR/DNI
- No resuscitation attempted (declared deceased in field by EMS)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openThe MetroHealth System
Cleveland, Ohio, United States
- Lance Wilson Attending Physician and Professor, Emergency Medicine, MD · Contact216-978-6274lwilson@metrohealth.org
- Julie Nichols Research Coordinator, RN · Contact(216) 957-6488jnichols@metrohealth.org
- Jeremiah Escajeda, MD · Sub-investigator
- Thomas Noeller, MD · Sub-investigator
- Joseph Piktel, MD · Sub-investigator
Study team
Sponsor
MetroHealth Medical Center
Study ID STUDY00001031
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.